HC-7366

Clinical trials for HC-7366 explained in plain language.

Never miss a new study

Get alerted when new HC-7366 trials appear

Sign up with your email to follow new studies for HC-7366, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug cocktail aims to tame kidney cancer

Disease control Recruiting now

This early-phase trial is testing whether adding an experimental drug called HC-7366 to standard immunotherapy drugs (nivolumab and ipilimumab) can help control advanced clear cell kidney cancer. About 35 adults with stage IV disease will receive the combination. The main goal is…

Matched conditions: HC-7366

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

HC-7366

Get alerted when new HC-7366 trials appear

New drug cocktail aims to tame kidney cancer